Over the past decade, several molecular epidemiological studies have been performed to identify the association of PON1 rs662, rs854560, LEP rs7799039G>A, and LEPR rs1137101 polymorphisms with susceptibility to breast cancer, but the findings have been conflicting. Here, LEP is linked to breast cancer.